A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study.

Tomoshi TsuchiyaKeitaro MatsumotoTakuro MiyazakiRyoichiro DoiShoji TokunagaHiroyuki YamaguchiKoichi TomoshigeHironosuke WatanabeTakeshi NagayasuKenji Sugio

Published in: BMC cancer (2021)

Registry number: UMIN000027435 . Registered May 22, 2017.

Keyphrases

phase ii study
open label
study protocol
clinical trial
locally advanced
randomized controlled trial
placebo controlled
squamous cell carcinoma
radiation therapy
combination therapy
double blind
prognostic factors